Skip to main content
. 2025 Mar 4;14(5):1716. doi: 10.3390/jcm14051716
ACS Acute Coronary Syndrome
AMI Acute Myocardial Infarction
AUC Area under the curve
AUROC Area under the receiver operating characteristic
CAPRICORN CArvedilol Post-infaRct survIval COntRolled evaluatioN
EPHESUS Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction
GRACE Global Registry of Acute Coronary Events
GUSTO Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
ICU Intensive Care Unit
LASSO Least Absolute Shrinkage and Selection Operator
MINAP Myocardial Ischemia National Audit Project
NSTEMI Non-ST-Elevation Myocardial Infarction
NT-proBNP N-terminal prohormone of brain natriuretic peptide
OASIS Oxford Acute Severity of Illness Score
OPTIMAAL Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan
PCI Percutaneous Coronary Intervention
PPCI Primary Percutaneous Coronary Intervention
PURSUIT Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin
ROC Receiver operating characteristic
STEMI ST-Elevation Myocardial Infarction
TIMI Thrombolysis in Myocardial Infarction
VALIANT VALsartan In Acute Myocardial Infarction
VIF Variance Inflation Factor